Published in J Thromb Haemost on February 01, 2005
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood (2008) 1.94
The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nat Rev Nephrol (2009) 1.38
Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol (2011) 1.32
An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis. Cytokine (2014) 0.84
The physiology of cardiovascular disease and innovative liposomal platforms for therapy. Int J Nanomedicine (2013) 0.81
Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med (1998) 2.78
Acute renal infarction. Clinical characteristics of 17 patients. Medicine (Baltimore) (1999) 2.00
The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood (1999) 1.87
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med (1990) 1.83
Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment. Am J Clin Oncol (1999) 1.74
Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem (1992) 1.69
Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J Clin Microbiol (1995) 1.66
Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis (1997) 1.57
Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem (2000) 1.56
Plasminogen activator inhibitor type 1 and outcome after successful cardiopulmonary resuscitation. Crit Care Med (2001) 1.53
Three-dimensional echocardiography using a transoesophageal imaging probe. Potentials and technical considerations. Eur Heart J (1996) 1.51
Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB. Eur J Vasc Endovasc Surg (2012) 1.50
Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J (2000) 1.50
Bartonella bacilliformis stimulates endothelial cells in vitro and is angiogenic in vivo. Am J Pathol (1990) 1.48
Borrelia burgdorferi as an etiologic agent in chronic heart failure? Scand J Infect Dis Suppl (1991) 1.48
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study. J Thromb Haemost (2012) 1.48
Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytes. Blood (1999) 1.45
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis? Int Arch Allergy Immunol (1998) 1.44
[Coronary stents, dual antiplatelet therapy and peri-operative problems]. Anaesthesist (2007) 1.44
Role of granulocyte elastase in the formation of hemorrhagic shock-induced gastric mucosal lesions in the rat. Crit Care Med (1996) 1.42
Clinical outcome of Borrelia burgdorferi related dilated cardiomyopathy after antibiotic treatment. Lancet (1992) 1.42
Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function. Eur J Clin Invest (1998) 1.41
Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J (1993) 1.41
Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. J Biol Chem (1979) 1.39
Dynamics of NF kappa B and Ikappa Balpha studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNa by fluorescence resonance energy transfer. J Biol Chem (2000) 1.38
["Inappropriate" thrombolysis in suspected myocardial infarct]. Wien Klin Wochenschr (2000) 1.37
Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood (1999) 1.36
Interactions between live Bartonella bacilliformis and endothelial cells. J Infect Dis (1992) 1.31
Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol (2007) 1.26
M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur J Immunol (1999) 1.25
Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J (2001) 1.20
The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor. J Biol Chem (1994) 1.18
Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci (1996) 1.18
The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest (1997) 1.17
Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J (1987) 1.15
Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol (1998) 1.15
Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J Clin Invest (2000) 1.13
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood (1994) 1.12
Adenovirus-mediated expression of green fluorescent protein. Gene Ther (1997) 1.12
Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation (2002) 1.12
Direct stimulatory effect of low-intensity 670 nm laser irradiation on human endothelial cell proliferation. Br J Dermatol (2003) 1.11
Complement in atherosclerosis: friend or foe? J Thromb Haemost (2011) 1.11
Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem (1997) 1.11
Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood (2001) 1.10
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J (2001) 1.08
Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities. Br J Pharmacol (2012) 1.07
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. Heart (2008) 1.07
Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur J Clin Invest (2005) 1.05
Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond) (2012) 1.01
Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue. J Biol Chem (2001) 1.01
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb Haemost (2010) 1.01
Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian Wiktor Stent Study Group and European Paragon Stent Investigators. J Am Coll Cardiol (2000) 1.01
Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B. Biochem Biophys Res Commun (1998) 1.00
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation (1992) 1.00
Capsule endoscopic appearance of the small-intestinal mucosa in Whipple's disease and the changes that occur during antibiotic therapy. Endoscopy (2007) 1.00
Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B. Cell Mol Life Sci (2008) 0.99
Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. Thromb Res (2001) 0.98
The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med (2000) 0.98
TrkB and neurotrophin-4 are important for development and maintenance of sympathetic preganglionic neurons innervating the adrenal medulla. J Neurosci (1998) 0.97
Nomograms for the prediction of patient's plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apher (1987) 0.97
Genotype-phenotype correlation in myotonic dystrophy. Clin Genet (1998) 0.97
Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay. J Thromb Haemost (2009) 0.97
Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo. Arterioscler Thromb Vasc Biol (1997) 0.97
Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J (1998) 0.97
Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost (1985) 0.97
PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease. Thromb Res (2001) 0.96
Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer. Eur Heart J (1988) 0.96
Alpha-catulin, a Rho signalling component, can regulate NF-kappaB through binding to IKK-beta, and confers resistance to apoptosis. Oncogene (2007) 0.94
Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol (2000) 0.94
Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors. Invasion Metastasis (1985) 0.94
Inflammation and coagulation in atherosclerosis. Hamostaseologie (2013) 0.93
Arterial remodelling of native human coronary arteries in patients with unstable angina pectoris: a prospective intravascular ultrasound study. Heart (1999) 0.93
Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology (2001) 0.93
Plasminogen activators and their inhibitors in arthritic disease. Ann N Y Acad Sci (1992) 0.93
Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. Proc Natl Acad Sci U S A (1989) 0.93
Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line. J Biol Chem (1986) 0.93
Histopathological findings in experimental aneurysms embolized with conventional and thrombogenic/antithrombolytic Guglielmi coils. Minim Invasive Neurosurg (1999) 0.92
Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology. Acute Card Care (2011) 0.92
c-ret regulates cholinergic properties in mouse sympathetic neurons: evidence from mutant mice. Eur J Neurosci (2004) 0.92
Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes. Eur J Clin Invest (2006) 0.92
Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas. J Urol (1988) 0.91
Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation (1995) 0.91
Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit Care Med (2000) 0.91
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur Heart J (2013) 0.91
Vienna Transdanube Aging "VITA": study design, recruitment strategies and level of participation. J Neural Transm Suppl (2002) 0.90
Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery (1990) 0.90